Document is current

Any future updates will be listed below

A Budget Impact Analysis of the Introduction of Erythropoiesis Stimulating Agent Subsequent Entry Biologics for the Treatment of Anemia of Chronic Kidney Disease in Canada

Crossref DOI link: https://doi.org/10.1186/s40697-014-0028-3

Published Online: 2014-11-11

Published Print: 2014-01-01

Update policy: https://doi.org/10.1177/sage-journals-update-policy

About CrossMark